Edmund Harrigan, Director at Karuna Therapeutics, Inc. (KRTX), sold 20,000 shares at $83.32 ($1.7M) on 2020-08-12, disclosed to the SEC on 2020-08-14.
Open-market sale of $1.7M KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.32 | 10,000 | $833K | 50.0% |
| 2 | $83.32 | 10,000 | $833K | 50.0% |
| Total | $83.32 avg | 20,000 | $1.7M | 100% |
| Filing → |
| KRTX | SELL | 2020-06-15 | $2.8M | — | Filing → |
| ACAD | BUY | 2016-08-18 | $33K | — | Filing → |